ES458957A1 - 1-aryloxy-2 - hydroxy - 3 - aminopropanes and process for their preparation - Google Patents

1-aryloxy-2 - hydroxy - 3 - aminopropanes and process for their preparation

Info

Publication number
ES458957A1
ES458957A1 ES458957A ES458957A ES458957A1 ES 458957 A1 ES458957 A1 ES 458957A1 ES 458957 A ES458957 A ES 458957A ES 458957 A ES458957 A ES 458957A ES 458957 A1 ES458957 A1 ES 458957A1
Authority
ES
Spain
Prior art keywords
formula
adrenolytic
reacting
compound
aminopropanes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES458957A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES458957A1 publication Critical patent/ES458957A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyridine Compounds (AREA)

Abstract

Novel compounds of the formula I are prepared by reacting a 2,3-oxidopropyl phenyl ether, or a 3-halo-2-hydroxypropyl phenyl ether, with an appropriately substituted amine, or by reacting a compound of the formula V with the compound X-R<4>. The symbols in the formulae I and V have the meaning given in the patent claim. The compounds of formula I, and their physiologically tolerated acid addition salts, have valuable therapeutic properties, in particular beta -adrenolytic, beta 1-adrenolytic and/or hypotensive and/or antiarrhythmic properties.
ES458957A 1976-05-25 1977-05-19 1-aryloxy-2 - hydroxy - 3 - aminopropanes and process for their preparation Expired ES458957A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2623314A DE2623314C2 (en) 1976-05-25 1976-05-25 1-aryloxy-2-hydroxy-3-aminopropanes, processes for their preparation and pharmaceuticals containing them

Publications (1)

Publication Number Publication Date
ES458957A1 true ES458957A1 (en) 1978-07-16

Family

ID=5978907

Family Applications (1)

Application Number Title Priority Date Filing Date
ES458957A Expired ES458957A1 (en) 1976-05-25 1977-05-19 1-aryloxy-2 - hydroxy - 3 - aminopropanes and process for their preparation

Country Status (18)

Country Link
JP (1) JPS5312827A (en)
AT (1) AT354421B (en)
AU (1) AU511704B2 (en)
BE (1) BE855041A (en)
CA (1) CA1108633A (en)
CH (5) CH637105A5 (en)
DE (1) DE2623314C2 (en)
DK (1) DK227177A (en)
ES (1) ES458957A1 (en)
FI (1) FI67698C (en)
FR (1) FR2353520A1 (en)
GB (1) GB1577670A (en)
HU (1) HU179198B (en)
IL (1) IL52148A (en)
IT (1) IT1077193B (en)
NL (1) NL7705587A (en)
SE (1) SE440903B (en)
ZA (1) ZA773120B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415622A1 (en) * 1978-01-25 1979-08-24 Lipha AMINO ALCOHOLS DERIVED FROM METHYL ORTHO-HYDROXY CINNAMATE APPLICABLE ESPECIALLY AS MEDICINAL PRODUCTS
DE2824764A1 (en) * 1978-06-06 1979-12-20 Hoechst Ag NEW PYRIDYL PIPERAZINE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION
EP0008711B1 (en) * 1978-08-15 1981-11-04 Smithkline Beckman Corporation A method of preparing a 2-hydroxy-3-isopropyl or a 2-hydroxy-3-tert-butylaminopropyl aromatic ether
FR2459235A1 (en) * 1979-06-14 1981-01-09 Sanofi Sa NOVEL SULFONYL-ANILINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
JPH0629833B2 (en) * 1984-06-15 1994-04-20 株式会社島津製作所 Fatigue testing machine
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
DK1188747T3 (en) 1999-05-24 2006-01-23 Mitsubishi Pharma Corp Phenoxypropylamine compounds
DE19941657A1 (en) * 1999-09-01 2001-03-08 Schwabe Willmar Gmbh & Co Cinnamic acid nitriles, process for their preparation and use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA945172A (en) * 1969-02-21 1974-04-09 Imperial Chemical Industries Limited Alkanolamine derivatives
FR2132570B1 (en) * 1971-04-09 1974-08-02 Lipha
BE791650R (en) * 1971-11-18 1973-05-21 Ici Ltd ALKANOLAMINE DERIVATIVES.
ES411826A1 (en) * 1973-02-20 1976-01-01 Liade Sa Lab Process for preparing pharmacologically active 1-aryloxy-2- propanolamines

Also Published As

Publication number Publication date
DK227177A (en) 1977-11-26
ATA370177A (en) 1979-06-15
HU179198B (en) 1982-09-28
SE440903B (en) 1985-08-26
BE855041A (en) 1977-11-25
JPS5312827A (en) 1978-02-04
CH637108A5 (en) 1983-07-15
SE7706059L (en) 1977-11-26
FR2353520A1 (en) 1977-12-30
FR2353520B1 (en) 1980-07-25
AU511704B2 (en) 1980-09-04
IL52148A0 (en) 1977-07-31
FI67698B (en) 1985-01-31
CH640507A5 (en) 1984-01-13
NL7705587A (en) 1977-11-29
AU2543477A (en) 1978-11-30
FI67698C (en) 1985-05-10
CH637107A5 (en) 1983-07-15
ZA773120B (en) 1978-04-26
DE2623314C2 (en) 1984-08-02
IL52148A (en) 1982-07-30
CA1108633A (en) 1981-09-08
AT354421B (en) 1979-01-10
IT1077193B (en) 1985-05-04
CH637105A5 (en) 1983-07-15
GB1577670A (en) 1980-10-29
FI771630A (en) 1977-11-26
DE2623314A1 (en) 1977-12-08
CH637109A5 (en) 1983-07-15
JPS6214545B2 (en) 1987-04-02

Similar Documents

Publication Publication Date Title
ES8703150A1 (en) New B-Carboline-3-oxadiazolyl derivatives, method of preparing the same and their use.
ES460040A1 (en) 4-hydroxyphenylalkanolamine derivatives and preparation thereof
ZA826755B (en) Substituted phenylsulfonylurea derivatives,a process for their preparation and their use as herbicides,and new intermediate products for their preparation
ES458957A1 (en) 1-aryloxy-2 - hydroxy - 3 - aminopropanes and process for their preparation
SE7604476L (en) PROCEDURE FOR PREPARING 1- (3,3,3-TRIARYLPROPYL) -4-PHENYL-4-PIPERIDINEMETHANOL COMPOUNDS
ES471650A1 (en) Triphendioxazine dyestuffs
GB1515019A (en) Substituted imidazolidines and pharmaceutical uses thereo
ES388879A1 (en) 1-(2&#39;-cyano-phenoxy)-2-hydroxy-3-ethylamino-propane and salts thereof
IL70258A (en) 1,3,4,5-tetrahydrobenzazepine and benzdiazepine derivatives,their preparation and pharmaceutical compositions containing them
ES444481A1 (en) 2-Aminoacetamido-{60 -phenylbenzylideneaminoalkanol derivatives and process for the preparation thereof
ES445812A1 (en) Phthalimidine and benzisothiazoline derivatives
SE7701107L (en) BIOLOGICALLY ACTIVE AMIDES
GB1531611A (en) (indolin-1-yl)-guanidines
GB1341170A (en) Alkyl sulphonic acid esters of 1,3,2-oxazaphospha-cyclic compounds
ES479233A1 (en) Procedure for the obtaining of antraquinone derivatives. (Machine-translation by Google Translate, not legally binding)
ES461718A1 (en) Phenoxyphenoxyalkane derivatives process for their preparation and herbicidal compositions containing them
ES433690A1 (en) Preparation of 1,8-naphthyridine derivatives
CH608797A5 (en) Process for the preparation of heterocyclic compounds
ES423460A1 (en) Procedure for the preparation of 7-aminodesacetoxicefalosporanico acid. (Machine-translation by Google Translate, not legally binding)
ES472897A1 (en) Method of preparing antraquinone derivatives (Machine-translation by Google Translate, not legally binding)
ES8600206A1 (en) Procedure for the preparation of derived alkylenodiamines (Machine-translation by Google Translate, not legally binding)
ES429698A2 (en) Procedure for the preparation of bencilamines. (Machine-translation by Google Translate, not legally binding)
GB1414370A (en) Benzodiazepines and their production
ES452392A1 (en) Procedure for the preparation of new substitute arilalcohylamins. (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990201